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   The extracellular microenvironment plays a key role in regulation of cellular functions 
and growth control. We show here that membrane-type 1 matrix metalloproteinase 
(MT1-MMP) acts as a growth promoter in confluent culture. When MT1-MMP was silenced 
in HT1080 fibrosarcoma cells, cells created three dimensional (3D) fibronectin matrix in a 
confluent culture, and growth of cells embedded within it was retarded. Formation of 3D 
fibronectin matrix initiated by MT1-MMP silencing was impeded by knockdown of either FN 
or integrin β1, which resulted in restoration of cell growth. When cells in 3D fibronectin 
matrix were treated with integrin β1 neutralizing antibody, cells underwent S phase entry. 
These results suggest that MT1-MMP prevents growth suppression by 3D fibronectin matrix, 
which is mediated through integrin β1. 
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Tissue development, remodeling, and homeostasis are governed by adhesion of cells to 
extracellular matrix (ECM) and neighboring cells. The ECM not only provides cell anchorage 
but also regulates gene expression, cell proliferation, differentiation, and motility [1,2]. It is 
reorganized and remodeled by synthesis, contraction, and degradation. The integrin family of 
transmembrane proteins forms heterodimers that function as receptors for ECM proteins. 
Cells predominantly interact with the ECM through integrins, which induces the formation of 
cell-matrix adhesions including focal adhesions, fibrillar adhesions and other variants such as 
nascent adhesions, focal complexes and three-dimensional (3D) matrix adhesions, as well as 
the degradative structure podosomes and invadopodia [1-3].  
Recently it has become clear that stiffness and topology of ECM surrounding cells 
regulates integrin signals and cell phenotype. The stiffness of ECM is regulated by its 
composition and organization [4]. When cells are cultured within 3D matrices including 
collagen gel, matrigel, and fibroblasts-derived 3D matrix, integrin signals are reduced 
compared with tissue culture dishes (2D), which is insufficient to support cell proliferation 
[5-7]. Tumor cell often have abnormal interactions with ECM due to alternations in integrins 
and ECM degrading enzymes such as matrix metalloproteinases (MMPs) [1,2]. 
MMPs are considered as key enzymes in tumor progression, as they degrade/modify 
ECM and cleave membrane proteins [8]. Among them, membrane-type 1 MMP (MT1-MMP) 
plays a significant role in tumor progression. It was originally identified as a tumor-specific 
activator of MMP-2 [9] and is now known to activate MMP-13 and degrade a wide range of 
ECM components, including collagens, laminins, and fibronectin (FN) [8]. This enzyme also 
processes and interacts with membrane proteins such as integrins, CD44, syndecan-1, and 
tissue transglutaminase [8,10-12]. It has been demonstrated that MT1-MMP promotes cell 
migration and invasion [13-16], and serves as a collagenolytic growth factor that provides 
tumor cells with the space to grow but not the ability to accelerate proliferative responses by 
overcoming the growth-suppressive signals from 3D collagen matrix [17-19]. 
FN assembly is a cell-dependent process, as binding to cell-surface integrins is necessary 
to initiate FN polymerization and assembly. Subsequent steps convert FN into a dense 3D 
meshwork of interconnected assembled FN that provides a dynamic environment for cells 
[20,21]. Oncogenically transformed cells are known to exhibit decreased synthesis and 
increased ability to degrade FN, resulting in a decrease of FN matrix [22]. Studies from our 
and other laboratories have indicated that MT1-MMP prevents FN matrix assembly, which 
causes promotion of cell motility [23,24]. In this study, we demonstrate that MT1-MMP 
promotes cell proliferation by impeding formation of 3D FN matrix. 
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1. Materials and methods 
 
2.1. Cell culture and reagents  
 
HT1080 cells were obtained from the Health Science Research Bank (Osaka, Japan). The 
cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Sigma-Aldrich, St 
Louis, MO, USA) supplemented with 10% fetal bovine serum. An anti-MT1-MMP antibody 
was gifted by Fuji Fine Chemicals (Toyama, Japan). Glass coverslips were purchased from 
Asahi Techno Glass (Tokyo, Japan). The immunological reagents used were 
anti-retinoblastoma protein (pRb), anti-phosphorylated (pSer807/811) Rb (ppRb), anti-paxillin, 
and anti-extracellualr signal-regulated kinase (ERK) 2 antibodies (BD Biosciences, Bedford, 
MD, USA); anti-FN and anti--tubulin antibodies (Sigma-Aldrich); anti-integrin β1 and 
anti-p21Cip1 antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA); an 
anti-phospho-p44/42 MAPK antibody (Cell Signaling Technology, Danvers, MA, USA); an 
inhibitory anti-integrin β1 antibody (4B4: Beckman Coulter, Fullerton, CA, USA); a mouse 
control IgG (Dako, Denmark); Rhodamine-labeled phalloidin, DAPI, and Alexa Fluor-labeled 
secondary antibodies (Molecular Probes, Eugene, OR, USA).  
 
2.2. Expression plasmids and transfection  
 
A fluorescent ubiqutination-based cell cycle indicator, pFucci-G1 Orange, was purchased 
from MBL (Nagoya, Japan). pFucci-G1 Orange was transfected into HT1080 cells by 
standard calcium phosphate methods and selected with G418 to establish stable transfectants.  
 
2.3. Small interfering RNA (siRNA)-mediated protein knockdown  
 
siRNA for negative control and human FN were purchased from Qiagen. The siRNA 
sequences were mt1-mmp, 5’-GCGAUGAAGUCUUCACUUATT; integrin β1, 
5’-AAUGUAACCAACCGUAGCATT. Cells were transfected with 20 nM of siRNA 
duplexes in Opti-MEM (Gibco) using Lipofectamine RNAi MAX (Invitrogen), according to 
the manufacturer’s instructions, and were incubated for 48 h. 
 
2.4. Immunoblotting  
 
Cells were washed with phosphate-buffered saline (PBS), and homogenized in SDS lysis 
buffer containing 10 mM Tris-HCl (pH 7.5), 100 mM NaCl, 5 mM EDTA, 2 mM Na3VO4, 2 
mM NaF, and 1% SDS. Protein concentration was determined using BCA assay (Pierce, 
Rockford, IL, USA). Samples were separated by electrophoresis on SDS-polyacrylamide gels 
5 
 
and transferred onto nitrocellulose membranes. The blots were analyzed using Odyssey 
infrared imaging system (Li-COR Bioscience, Lincoln, NE, USA). 
 
2.5. Immunofluorescence staining  
 
Cells gown on the glass coverslips were washed with PBS, fixed with 4% 
paraformaldehyde for 15 min, and permeabilized with 0.5% Triton X-100 for 5 min. After 
blocking with Image-iT FX signal enhancer (Molecular Probes), cells were reacted with 
indicated antibodies. Samples were observed by confocal laser scanning microscopy LSM510 
(Carl Zeiss, Jena, Germany).  
 
2.6. 5-etynyl-2’-deoxyuridine (EdU) labeling and detection 
 
Cell proliferation and S-phase entry in cells were measured by cultivation with EdU (10 
μM) for 2 h, according to the manufacturer’s instructions. EdU incorporation was determined 
by confocal laser microscopy using Click-iT EdU Alexa Fluor 555 imaging kit (Invitrogen) 
and analyzed with image J software. 
 
2.7. Cell viability  
 
HT1080 cells were cultured with 96-well culture plates for indicated periods. Cell 
viability was determined by assaying viable cell numbers using a Cell Counting Kit-8 (Dojin 
Laboratory, Kumamoto, Japan). The living cell number was assessed by measuring the 








3.1. MT1-MMP induces cell growth  
 
HT1080 cell line, which has one activated allele of N-ras and expresses MT1-MMP, 
shows the invasive phenotype [23,25]. We previously reported that treatment of HT1080 cells 
with the synthetic MMP inhibitor BB94 promotes dexamethasone-induced FN assembly, and 
down-regulates cell motility, concluding that MT1-MMP stimulates cell migration and 
invasion by negatively regulating FN assembly [23].  
 In this study, we examined the effect of MT1-MMP silencing on cell proliferation in a 
dense culture condition, which results in FN assembly. First, FN assembly and growth pattern 
of MT-MMP-silenced HT1080 cells cultured in a dense condition were visualized 
three-dimensionally (Fig. 1A). FN fibrils assembled at cell-cell interface on both basal and 
lateral surface of MT1-MMP-silenced HT1080 cells when cells were cultured in a dense 
condition. Three dimensional images which are stacked up on the bottom z section 
demonstrated that assembled FN fibrils interconnect and then form a meshwork surrounding 
the cells three dimensionally. A part of FN meshwork was hidden by overlaid nuclei (red 
hatched circles) and some nuclei were present under FN meshwork (yellow hatched circles). 
Thus, MT1-MMP-silenced HT1080 cells were embedded in 3D FN matrix. Next, we 
examined the expression of growth-associated molecules by immunoblotting. MT1-MMP 
knockdown resulted in the increase of cell-associated FN level and cyclin-dependent kinase 
inhibitor p21Cip1 expression and the decrease of phosphorylated ERK and pRB at confluence 
(Fig. 1B). The number of EdU-incorporating mitotic cells was significantly attenuated in the 
cells transfected with MT1-MMP siRNA (Fig. 1C); contrary, the number of cells in G1 phase 
was remarkably increased in MT1-MMP-silenced cells, which was accompanied with 3D FN 
matrix formation (Fig. 1D). Concomitantly, cell viability was reduced by MT1-MMP 
knockdown (Fig. 1E). These results suggest that MT1-MMP regulates cell cycle progression 
and thereby cell proliferation in confluent cultures. 
 
3.2. Disruption of FN matrix assembly by MT1-MMP stimulates cell proliferation 
 
Among the FN binding integrins, integrin α5β1 is considered of major importance for the 
formation of FN assembly [9,10]. HT1080 cells were transfected with siRNA for MT1-MMP 
and/or integrin β1, and formation of 3D FN matrix was examined. Cell-associated FN 
increased by MT1-MMP knockdown was reduced by double-knockdown with integrin β1, 
(Fig. 2A), which caused only short FN fibrils but not 3D FN matrix formation (Fig. 2B). 
Formation of 3D FN matrix induced cell matrix adhesions at both basal and lateral surface of 
MT1-MMP-silenced cells. FN assembly is known to require cellular FN synthesis [20,21]. To 
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confirm it, HT1080 cells were transfected with siRNA for MT1-MMP and/or FN. 
Cell-associated FN increased by MT1-MMP knockdown was abrogated by 
double-knockdown with cellular FN, which resulted in the loss of 3D FN matrix (Fig. 2C). 
These results show that both cellular FN and integrin β1 are crucial for 3D FN matrix 
formation induced by MT1-MMP knockdown.  
In order to examine the effect of 3D FN matrix on HT1080 cell proliferation, cells were 
transfected with siRNA for MT1-MMP and/or integrin β1 or FN, and cultured for 2 days at 
high cell density. Cell proliferation attenuated by MT1-MMP knockdown was recovered by 
co-transfection of siRNA for FN or integrin β1, whereas neither integrin β1 nor FN 
knockdown alone affected cell proliferation significantly (Fig. 2D). These results indicate that 
assembled FN matrix interferes with HT1080 cell proliferation. 
 
3.3. Integrin β1 mediates growth suppression by 3D FN matrix 
 
To seek the molecular mechanism by which 3D FN matrix suppresses cell growth, we 
examined the effect of integrin β1 inhibitory antibody 4B4 that interferes with interaction of 
integrin β1 with its ligand. Cell-associated FN increased by MT1-MMP knockdown was 
attenuated by treatment with 4B4 for 12 h, which caused the loss of 3D FN matrix (Fig. 3A). 
These results further confirmed that integrin β1 is involved in 3D-FN matrix formation. Next, 
we examined the role of integrin β1 in regulation of cell proliferation in 3D FN matrix using 
the inhibitory antibody. After FN matrix assembly was completed by MT1-MMP silencing, 
cells were incubated with 4B4 antibody for 2 h, and then the number of mitotic cells was 
analyzed by EdU-incorporation (Fig. 3A). Although the number of EdU-incorporating mitotic 
cells was unaffected by 4B4 treatment in mock-transfected cells, the reduction of mitotic cells 
by MT1-MMP-silencing was partially rescued by treatment with 4B4 (Fig. 3B and C). These 
results suggest that integrin β1 mediates growth suppression of HT1080 cells embedded 






Focal adhesions are sites of integrin clustering that link the actin cytoskeleton to ECM 
and develop to fibrillar adhesions, which facilitates FN assembly by creating cytoskeletal 
tension [1,2]. This increased cytoskeletal tension is required for further formation of FN fibril 
and 3D FN matrix. We have previously reported that MT1-MMP degrades assembled FN on 
cell surface, which accelerates turnover of focal adhesions and thereby prevents maturation of 
focal adhesion and FN assembly, resulting in promotion of cell migration [23]. We 
demonstrate here that destruction of 3D FN matrix by MT1-MMP releases confluent cells 
from the growth suppression by 3D FN matrix. 
Oncogenically transformed cells are known to exhibit decreased synthesis and increased 
ability to degrade FN, resulting in a decrease of FN matrix [22]. Silencing of MT1-MMP 
caused FN assembly in HT1080 cells to form 3D FN matrix, and cells were embedded in it 
(Fig. 1A). Cells on 2D matrices exhibit behaviors drastically different from cells within 3D 
matrices. Culturing cells on 2D substrates induces integrin clustering and robust focal 
adhesion formation and thereby generates signals, which promote cell proliferation and 
migration. In contrast, integrin signals are reduced in cells embedded in 3D matrices 
including collagen gel, matrigel, and fibroblasts-derived 3D matrix, and thereby cell 
proliferation and migration are suppressed [1-7]. Three-dimensional broad distribution of 
integrin on cells embedded in 3D matrices may be insufficient to generate growth signal.  
MT1-MMP knockdown resulted in formation of 3D FN matrix and growth suppression in 
HT1080 cells (Fig. 1). Silencing of FN or integrin β1, which interferes with FN assembly, 
rescued growth suppression induced by MT1-MMP knockdown (Fig. 2), indicating that 3D 
FN matrix formed through MT1-MMP knockdown caused growth suppression of HT1080 
cells. Confluent MT1-MMP-silenced HT1080 cells cause FN assembly three-dimensionally 
along cell-cell adhesion and the lateral surface (Fig. 2). Paxillin was co-localized 
three-dimensionally with assembled FN in the dense population of cells (Fig. 2). The 
three-dimensionally enlarged cell-ECM adhesions of dense cell population visualized by 
paxillin staining suggest the reduced signal transduction for cell proliferation. Addition of 
neutralizing antibody against integrin β1 to HT1080 cells interferes with FN assembly 
promoted by MT1-MMP knockdown. Furthermore, treatment of cells already embedded in 
FN matrix through MT1-MMP silencing with the neutralizing antibody recovered cell 
proliferation quickly (Fig. 3). It is known that the association of integrin α2β1 with collagen 
fibrils generates the growth-suppressive signals in normal epithelial or cancer cells embedded 
in 3D collagen [26-28]. These results suggest that integrin β1 is involved in not only FN 
assembly but also maintenance of cell-FN matrix adhesion, which negatively regulates 
integrin clustering associated with signal transduction for cell proliferation. 
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Recently it has become clear that stiffness and topology of ECM surrounding cells 
regulates integrin signals and cell phenotype [1-7]. Cell cycle progression, cell spreading and 
cytoskeletal organization are inhibited due to decreased integrin signals, when cells are plated 
on low-stiffness substrate but not deformable 2D substrates. Tumor stroma is stiffer than 
normal one; a randomly organized, compliant normal stroma is tumor suppressive. As tumors 
grow, fibroblasts reorganize a loose stroma into stiffer one [4,29]. Our findings agree with 
previous results demonstrating that decreased FN matrix is observed in numerous tumors and 
tumor-derived cell lines [25] and indicate that MT1-MMP is responsible at least in part for 
destruction of FN matrix. The control of not only deposition but also degradation is crucial 
for reorganization and remodeling of ECM. There may be a delicate balance between 
deposition and degradation of ECM to create stiff tumor stroma that promotes growth and 
invasion of tumors. 
In conclusion, cells expressing MT1-MMP escape from growth suppressive condition by 
disrupting 3D FN matrix. As cellular functions including gene expression, cell proliferation, 
migration, and differentiation are controlled by ECM elasticity, further studies on regulation 
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Fig. 1. MT1-MMP induces cell growth. (A) MT1-MMP-silenced HT1080 cells plated on the 
glass coverslips were stained with DAPI and anti-FN antibody. Confocal image of cells with 
z section were taken and analyzed. The images at basal and lateral levels were shown at left. 
For z section analysis, 50 images are stacked up on the bottom z section (3D images). Red 
hatched circles show FN meshwork hidden by overlaid nuclei. Yellow hatched circles 
indicate nuclei hidden by FN meshwork. (B) HT1080 cells were transfected with siRNA for 
control (siScr) or MT1-MMP (siMT1). The cell lysates were immunoblotted with 
anti-MT1-MMP (MT1), anti-FN, anti-phosphorylated ERK (pERK), anti-ERK2, 
anti-phosphorylated pRb (ppRb), anti-pRb, anti-p21Cip1, or anti-tubulin antibodies. (C) 
HT1080 cells were transfected with siRNA for control or MT1-MMP and stained with DAPI 
and EdU. EdU-incorporating mitotic cells were observed by confocal laser scanning 
microscopy as described in “Materials and methods”, and then the percentages of cells 
immnoreactive for EdU were counted (right panel). (D) HT1080 cells stably expressing 
pFucci-G1 Orange were transfected with siRNA for control or MT1-MMP. Cells were stained 
with DAPI and anti-FN antibody, and then the percentages of cells in G1 phase were counted 
(right panel). Scale bar, 20 μm; columns, mean; bars, SD; *, p < 0.005. (E) HT1080 cells 
were transfected with siRNA for control or MT1-MMP, and then cultured within 96-well 
culture plates (5×103 cells/well) for indicated periods. Cell viability was determined as 
described in “Materials and methods”. Cell viabilities were normalized to the levels of the 
cells transfected with control siRNA at day 1. Columns, mean; bars, SD; *, p < 0.005 
(compared to the siScr).  
 
Fig. 2. Disruption of FN matrix assembly stimulates cell proliferation. (A) HT1080 cells were 
transfected with siRNA for control, MT1-MMP, or integrin β1 (siIntβ1). The cell lysates were 
immunoblotted with anti-MT1-MMP, anti-integrin β1 (Intβ1), anti-FN, or anti-tubulin 
antibodies. (B) The cells were also stained with DAPI, anti-paxillin and anti-FN antibodies. 
The images at basal and lateral levels were shown. Arrowheads indicate cell matrix adhesions 
at lateral surface. (C) HT1080 cells were transfected with siRNA for control, MT1-MMP, or 
FN (siFN). The cell lysates were immunoblotted with anti-FN, anti-MT1-MMP, or 
anti-tubulin antibodies. The cells were also stained with DAPI and anti-FN antibody. Scale 
bars, 20 μm. (D) HT1080 cells were transfected with siRNA for control, integrin β1, FN 
and/or MT1-MMP and cultured with 96-well culture plates (1×104 cells/well) for 2 days. Cell 
viability was determined as described in “Materials and methods”. Cell viabilities were 
normalized to the levels of the cells transfected with control siRNA. Columns, mean; bars, 




Fig. 3. 3D FN matrix suppresses cell growth. (A) HT1080 cells were transfected with siRNA 
for control or MT1-MMP. The cells were treated with 10 μg/ml of control mouse IgG or 
anti-integrin β1 inhibitory antibody (4B4) for 12 h. The cell lysates were immunoblotted with 
anti-FN, anti-MT1-MMP, or anti-tubulin antibodies. Cells were also stained with DAPI, 
Rhodamine-labeled phalloidin (F-actin), and anti-FN antibody (right panel). (B) HT1080 
cells transfeced with siRNA for control or MT1-MMP were reattached to coverslips for 24 h. 
Then, the cells were treated with control mouse IgG or 4B4 for 2h and analyzed with 
immunostaining with DAPI and anti-FN antibody. EdU-incorporating mitotic cells were 
observed by confocal laser scanning microscopy as described in “Materials and methods”, 
and then the percentages of cells immnoreactive for EdU were counted. Scale bars, 20 μm. 
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